Your browser doesn't support javascript.
loading
Linc-ROR drive adriamycin resistance by targeting AP-2α/Wnt/ß-catenin axis in hepatocellular carcinoma.
Shi, Chuan-Jian; Lv, Min-Yi; Deng, Li-Qiang; Zeng, Wei-Qiang; Fu, Wei-Ming; Zhang, Jin-Fang.
Afiliação
  • Shi CJ; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.
  • Lv MY; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.
  • Deng LQ; Department of Pharmacy, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, 518028, People's Republic of China.
  • Zeng WQ; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.
  • Fu WM; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.
  • Zhang JF; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China. fuweiming76@smu.edu.cn.
Cell Biol Toxicol ; 39(4): 1735-1752, 2023 08.
Article em En | MEDLINE | ID: mdl-36576707

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article